血小板计数与血小板淋巴细胞比率作为头颈部鳞状细胞癌预后标志物的Meta分析
该Meta分析系统检索电子数据库,纳入报告血小板计数或血小板淋巴细胞比率(PLR)与头颈部鳞状细胞癌(HNSCC)预后相关性的研究。结果显示,血小板计数高于临界值与较差的总生存期(OS)相关(HR 1.81;95%CI 1.16-2.82),PLR高于临界值也与较差的OS相关(HR 1.64;95%CI 1.13-2.37)。结论认为血小板计数和PLR升高与HNSCC患者不良预后相关。
要点
- 血小板计数高于临界值与HNSCC患者较差的总生存期相关(HR 1.81;95%CI 1.16-2.82)。
- PLR高于临界值与HNSCC患者较差的总生存期相关(HR 1.64;95%CI 1.13-2.37)。
- 血小板计数和PLR升高可作为HNSCC预后不良的标志物。
核心结论
- 血小板计数和PLR升高与HNSCC患者不良预后相关。
研究设计与样本
- 系统检索电子数据库,纳入报告血小板计数或PLR与HNSCC预后相关性的研究。
- 血小板计数分析纳入8项研究、共4096例患者;PLR分析纳入9项研究、共2327例患者。
- 提取总生存期(OS)的风险比(HR)和95%置信区间(CI),采用随机效应模型估计合并HR。
主要发现
- 血小板计数大于临界值与较差OS相关(HR 1.81;95%CI 1.16-2.82)。
- 任何PLR大于临界值与较差OS相关(HR 1.64;95%CI 1.13-2.37)。
关键数值与推荐
- 血小板计数大于临界值对应OS的合并HR为1.81(95%CI 1.16-2.82)。
- PLR大于临界值对应OS的合并HR为1.64(95%CI 1.13-2.37)。
临床怎么用
- 在HNSCC患者预后评估中,可关注血小板计数和PLR升高提示的不良生存风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thrombocytosis is associated with the prognosis of various types of cancer. The purpose of this study was to quantify the prognostic impact of platelet count and platelet-lymphocyte ratio (PLR) in head and neck squamous cell carcinoma (HNSCC). METHODS: We systematically searched electronic databases and identified articles reporting an association between platelet count or PLR and HNSCC prognosis. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall survival (OS) were extracted, and the pooled HRs were estimated using random effect models. RESULTS: Eight studies that enrolled 4096 patients and 9 studies that enrolled 2327 patients were included in the platelet count and PLR analyses, respectively. A platelet count greater than the cutoff value was associated with poor OS (HR 1.81; 95% CI 1.16-2.82) and any PLR greater than the cutoff value was associated with poor OS (HR 1.64; 95% CI 1.13-2.37). CONCLUSION: Elevated platelet count and PLR are associated with poor prognosis in patients with HNSCC.
引用
- Takenaka Y, Oya R, Kitamiura T, et al. Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis. Head Neck. 2018. PMID: 30102821. doi:10.1002/hed.25366
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。